ABSTRACT
The Gerbich (Ge) antigens are a collection of high-incidence antigens carried on the red blood cell membrane glycoproteins, glycophorins C and D. Antibodies against these antigens are uncommon, and there have been only rare case reports of hemolytic disease of the fetus and newborn due to anti-Ge. In this case report, we present a neonate with severe anemia and hyperbilirubinemia due to anti-Ge3. Routine and special laboratory studies undertaken in this case suggested two mechanisms for the patient's hemolysis and persistent anemia. Antibody-dependent hemolysis was associated with early-onset hyperbilirubinemia, anemia, and a mild reticulocytosis, and inhibition of erythroid progenitor cell growth was associated with late anemia and normal bilirubin and reticulocyte values. Though rare, anti-Ge3 can be a dangerous antibody in pregnancy. Affected neonates may require intensive initial therapy and close follow-up for at least several weeks after delivery.
KEYWORDS
Gerbich - hemolysis - hemolytic disease of the newborn - red blood cells
REFERENCES
1
Reid M E, Spring F A.
Molecular basis of glycophorin C variants and their associated blood group antigens.
Transfus Med.
1994;
4
139-146
2 Reid M E, Lomas-Francis C. The Blood Group Antigen Factsbook. 2nd ed. San Diego, CA; Academic Press 2004: 403-418
3
Rosenfield R E, Haber G V, Kissmeyer-Nielsen F, Jack J A, Sanger R, Race R R.
Ge, a very common red-cell antigen.
Br J Haematol.
1960;
6
344-349
4
Peddle L J, Josephson J E, Lawton A.
Auto-donation in the management of placenta previa and erythroblastosis in a pregnancy complicated by Gerbich iso-immunization.
Vox Sang.
1970;
18
547-550
5
Reid M, Rector D, Danneskiold T.
Anti-Gerbich: a case report.
Immunohematology.
1984;
1
7-8
6
Sacks D A, Johnson C S, Platt L D.
Isoimmunization in pregnancy to Gerbich antigens.
Am J Perinatol.
1985;
2
208-210
7
Pinder L, Coleman R, Woodfield D G.
Polynesian patients of the Gerbich-negative phenotype Ge:-2–3.
Vox Sang.
1992;
63
74
8
Miller R, Volny M, Unger P, Shapiro A, Sirota R, Engel M.
A mild case of hemolytic disease of the newborn due to anti-Ge2,3 subclass IgG3.
Transfusion.
1996;
36
25S
9
Arndt P A, Garratty G, Daniels G et al..
Late onset neonatal anemia due to maternal anti-Ge: possible association with destruction of erythroid progenitors.
Transfus Med.
2005;
15
125-132
10
Bowman J M, Pollock J M, Manning F A, Harman C R, Menticoglou S.
Maternal Kell blood group alloimmunization.
Obstet Gynecol.
1992;
79
239-244
11
Vaughan J I, Manning M, Warwick R M, Letsky E A, Murray N A, Roberts I A.
Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
N Engl J Med.
1998;
338
798-803
12
Daniels G, Hadley A, Green C A.
Causes of fetal anemia in hemolytic disease due to anti-K.
Transfusion.
2003;
43
115-116
13
Denomme G A, Shahcheraghi A, Blackall D P, Oza K K, Garratty G.
Inhibition of erythroid progenitor cell growth by anti-Ge3.
Br J Haematol.
2006;
133
443-444
14 Brecher ME AABB Technical Manual. 15th ed. Bethesda, MD; American Association of Blood Banks 2005
15
Arndt P A, Garratty G.
A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Transfusion.
2004;
44
1273-1281
16
Sacks D A, Nance S J, Garratty G, Petrucha R A, Horenstein J A, Fotheringham N.
The monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus/newborn.
Am J Perinatol.
1993;
10
428-431
17 Klein H G, Anstee D J. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Oxford; Blackwell Publishing 2005: 496-498
18
Luban N L.
Hemolytic disease of the newborn: progenitor cells and late effects.
N Engl J Med.
1998;
338
830-831
19
Bony V, Gane P, Bailly P, Cartron J P.
Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation.
Br J Haematol.
1999;
107
263-274
20
Head D J, Lee Z E, Poole J, Avent N D.
Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation.
Br J Haematol.
2005;
129
130-137
Douglas P BlackallM.D.
Department of Pathology, Arkansas Children's Hospital
800 Marshall Street, Little Rock, AR 72202
eMail: blackalldouglasp@uams.edu